Nippon Express Co., Ltd. (Mitsuru Saito, President; hereinafter, “Nippon Express”), a Group company of Nippon Express Holdings, Inc. (Mitsuru Saito, President), has obtained IATA CEIV Pharma(*) pharmaceutical transport quality certification effective April 5 for its temperature-controlled facility “NX-PHARMA Logistics Hub Kansai Airport” located inside the international cargo area of Kansai International Airport.
Nippon Express has been participating in the KIX Pharma Community established by Kansai Airports Co., Ltd. (Yoshiyuki Yamaya, CEO) and striving to acquire CEIV Pharma certification with the support of that company. As an air cargo forwarder operating a CEIV Pharma-certified facility, Nippon Express will be providing safe and high-quality temperature-controlled transport services at Kansai International Airport
Nippon Express obtained the same certification in February 2021 for its Narita Temperature Controlled Hub near Narita Airport and has successfully constructed a pharmaceutical distribution network connecting gateway airports in eastern and western Japan.
The “Nippon Express Group Business Plan 2023 – Dynamic Growth” regards the pharmaceutical industry as a priority industry, and the NX Group has accordingly been enhancing and globally extending services to meet customer needs for increasingly sophisticated and diverse pharmaceutical logistics. The Group remains committed to providing a safe and secure pharmaceutical logistics platform.
Source: Nippon Express Holdings
